RS2 Healthcare Completes Investment in KMM Group and Appoints New CEO
RS2 Healthcare Partners, a Boston-based private equity firm focused on healthcare investments in the lower middle market, has completed its investment in KMM Group. Based in Hatboro, Pennsylvania, KMM is a vertically integrated precision contract manufacturer serving the medical device industry with complex components and tight-tolerance engineering solutions. This marks RS2's first new platform investment since rebranding to focus exclusively on healthcare. The firm praised KMM for its strong reputation, specialized capabilities, blue-chip customer base, and dedicated workforce. J. Mark King has been appointed as the company’s CEO, bringing over 30 years of experience in medical device manufacturing. KMM's co-founders John Shegda and Eric Wilhelm will remain involved in leadership roles, with Shegda becoming Chief Technology Officer and Wilhelm serving as Executive Vice President for business transformation. The investment is expected to support KMM’s growth while maintaining its culture and operational excellence.
Topics: healthcare manufacturing leadership change private equity